Symphera funding news – Munich-based Symphera Raises €2.4 Million in Seed Funding

Advanced laparoscopic surgical systems from it automate tool-switching. Technology from the company eliminates manual instrument changes. Surgeons can switch equipment like a multipen with a button, allowing them to focus during the process. The goal is to streamline surgical workflows, minimize operating time, and improve patient outcomes.

Read also - Battolyser Systems funding news – Dutch-based Battolyser Systems Secures €30Million in Series A Round Funding

The company's purpose matches healthcare trends to improve operating room efficiency and surgeon workspace. It's technology can meet the demand for more efficient surgeries, and prominent minimally invasive surgery experts and institutions support it.

Dr. Jan Engels, Investment Manager at HTGF, said: “With its surgical tool, Symphera addresses the entire spectrum of laparoscopy, from improving the standard workflow to robot-assisted applications, making Symphera a strong venture case in a highly interesting field.”

Monika Steger, Managing Director at Bayern Kapital, added: “With its all-in-one instrument, the Symphera team has developed a way to make shorter operations possible. Symphera’s existing prototype has convinced us and makes Symphera an exciting investment case for us in the medtech sector.”

It will use the extra funds to improve its product and conduct pre-clinical studies for certification. These stages are essential to commercializing their technology and enhancing laparoscopic surgery and patient care.

Christian Leikert, Managing Partner at CARMA FUND, commented: “We are intrigued by the company’s founders and its potential to revolutionize laparoscopic surgery with a straight-forward technology. Its potential future application in robotic and robotic-assisted surgery provides significant further upside potential to Symphera.”

About Symphera

Create an all-in-one surgical system to streamline minimally-invasive operations. By eliminating tool changes, Symphera simplifies and speeds up minimally invasive operations.